Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis

Nature

Volumn 394, Issue 6692, 1998, Pages 485-490

  Carmeliet, Peter ^a   Dor, Yuval ^b   Herber, Jean Marc ^c   Fukumura, Dai ^d   Brusselmans, Koen ^a   Dewerchin, Mieke ^a   Neeman, Michal ^e   Bono, Françoise ^c   Abramovitch, Rinat ^e   Maxwell, Patrick ^f   Koch, Cameron J ^g   Ratcliffe, Peter ^f   Moons, Lieve ^a   Jain, Rakesh K ^d   Collen, Désiré ^a   Keshet, Eli ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b HEBREW UNIVERSITY   (Israel)

^c SANOFI   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; GLUCOSE; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1; LYMPHOKINE; NUCLEAR PROTEIN; OXYGEN; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; GENE REPRESSION; GENE TARGETING; HYPOGLYCEMIA; HYPOXIA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; BLOOD FLOW; CELL DIVISION; CELL HYPOXIA; CELL LINE; CHO CELL; EXPERIMENTAL NEOPLASM; GENETICS; HAMSTER; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PHYSIOLOGY; STEM CELL; VASCULARIZATION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL HYPOXIA; CELL LINE; CHO CELLS; CRICETINAE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE TARGETING; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; OXYGEN; REGIONAL BLOOD FLOW; STEM CELLS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032581277     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/28867     Document Type: Article

References (30)

1. Bunn, H. F. & Poyton, R. O. Oxygen sensing and molecular adaptation to hyopoxia. Physiol. Rev. 76, 839-885 (1996).
2. Wenger, R. H. & Gassmann, M. Oxygen(s) and the hypoxia-inducible factor-1. Biol. Chem. 378, 609-616 (1997).
3. Semenza, G. L. Transcriptional regulation by hypoxia-inducible factor-1. Trends Cardiovasc. Med. 6, 151-157 (1996).
4. 2 homeostasis by hypoxia-inducible factor-1α. Genes Dev. 12, 149-162 (1998).
5. Dor, Y. & Keshet, E. Ischemia-driven angiogenesis. Trends Cardiovasc. Med. 7, 289-294 (1997).
6. Gartel, A. L., Serfas, M. S. & Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213, 138-149 (1996).
7. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
8. Price, B. D. & Calderwood, S. K. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res. 52, 3814-3817 (1992).
9. Little, E., Ramakrishnan, M., Roy, B., Gazit, G. & Lee, A. S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4, 1-18 (1994).
10. Wood, S. M. et al. Selection and analysis of a mutant cell line defective in the hypoxia inducible factor-1α subunit. Characterization of HIF-1α dependent and independent hypoxia-inducible gene expression. J. Biol. Chem. 273, 8360-8367 (1998).
11. Liebermann, D. A., Hoffman, B. & Steinman, R. A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199-210 (1995).
12. Cox, L. S. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J. Pathol. 183, 134-140 (1997).
13. Graeber, T. G. et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264-6277 (1994).
14. Strasser, A., Huang, D. C. & Vaux, D. L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333, F151-178 (1997).
15. Maxwell, P. H. et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104-8109 (1997).
16. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A. & Simon, C. M. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407 (1997).
17. Schmaltz, C., Harrigan Hardenbergh, P., Wells, A. & Fisher, D. E. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18, 2845-2854 (1998).
18. Collins, M. K., Perkins, G. R., Rodriguez Tarduchy, G., Nieto, M. A. & Lopez Rivas, A. Growth factors as survival factors: regulation of apoptosis. Bioessays 16, 133-138 (1994).
19. Lin, Y. & Benchimol, S. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol. Cell. Biol. 15, 6045-6054 (1995).
20. Vaupel, P. The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin. Pädiatr. 209, 243-249 (1997).
21. Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl Acad. Sci. USA 93, 14765-14770 (1996).
22. Graeber, T. G. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
23. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177-182 (1997).
24. An, W. G. et al. Stabilization of wild-type p53 by hypoxia-inducible factor-1α. Nature 392, 405-408 (1998).
25. Jiang, B. H., Rue, E., Wang, G. L., Roe, R. & Semenza, G. L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor-1. J. Biol. Chem. 271, 17771-17778 (1996).
26. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth-factor allele. Nature 380, 435-439 (1996).
27. Abramovitch, R., Frenkiel, D. & Neeman, M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Mag. Reson. Med. 39, 813-824 (1998).
28. Kobayashi, N., Kobayashi, K., Kouno, K., Horinaka, S. & Yagi, S. Effects of intra-arterial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats. Am. J. Physiol. 266, H1910-H1917 (1994).
29. Evans, S. M. et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 (2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide). Br. J. Cancer 72, 875-882 (1995).
30. Herbert, J. M. & Carmeliet, P. Involvement of u-PA in the anti-apoptotic activity of TGFβ for vascular smooth muscle cells. FEBS Lett. 413, 401-404 (1997).